When companies from a sector with a clear growth path get listed, too much money flows into them, sending valuations high. What follows is ...

Actress Anushka Sharma's Instagram post praising homeopathy has ignited a fierce debate. She shared her positive experiences with the alter...

Around 8,667 pharmaceutical companies claimed income tax deduction under “sales promotion expenses” and “gifts” during 2019-20, the income ...

The state administration on Sunday removed J&K flag from the civil secretariat building in Srinagar, with only the National Flag remaining ...

Following price caps on coronary stents and knee implants to increase access to affordable and quality healthcare, the minister says the in...

The government plans to review the existing drug price control measures to make medicines more affordable, while also undertaking "re-engin...

The department of pharmaceutical has also invoked special provisions under the DPCO to ensure compliance with the pricing order as well as ...

Under CGHS, government employees and pensioners can avail of cash less diagnostics and treatment at a subsidized rate.

The National Pharmaceutical Pricing Policy, 2011, seeks to evolve a formula to fix the maximum retail prices of 348 essential drugs.

The government's new drug pricing policy draft is facing stiff all-round opposition over fears that it will increase prices of medicines.

Prices of some cancer medicines may come down sooner than expected, providing relief to India’s over 20 lakh cancer patients.

All India Drug Action Network rejects draft proposal saying it legitimises overpricing and justifies super profit.

The company has received further demand notices from the government demanding an amount of Rs 47.70 crore in respect of the drug Salbutamol.

The government is all set to change the current way of fixing medicine prices, which gives companies the freedom to overcharge consumers. T...

The pharmaceutical industry’s recent offer to cut prices of 886 medicines to dissuade the government from going ahead with a tougher pricin...

Drug price regulator National Pharmaceutical Pricing Authority (NPPA) is set to become stronger, more transparent and receptive to industry...

The government may introduce a provision in the drugs and cosmetics Act asking doctors in individual private practice to give patients the ...